Study of Welltang- a Cell Phone-based Diabetes Management Application's Effect on Blood Glucose Control

Diabetes Mellitus Clinical Trial

Official title:

Study of Welltang- a Cell Phone-based Diabetes Management Application's Effect on Blood Glucose Control

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02313090
• Other study ID #: ChiCTR-IOR-14005515
• Status: Completed
• Phase: N/A
• First received: November 25, 2014
• Last updated: December 7, 2014
• Start date: January 2014
• Est. completion date: May 2014

Study information

• Verified date: December 2014
• Source: First Affiliated Hospital of Zhejiang University
• Contact: n/a
• Is FDA regulated: No
• Health authority: China: Ministry of Health
• Study type: Interventional

Clinical Trial Summary

The aim was to assess the impact of a cell phone-based diabetes management application (Welltang) on HbA1c, blood glucose, lipids, physical activity, weight, and blood pressure during 3 months. And hypoglycemic events, the satisfaction of the patients with Boyibang, their diabetes knowledge and self-care behaviors were also evaluated.

Description:

At baseline, all patients completed the Diabetes Self- Care Behavior Questionnaire and a Diabetes Knowledge Survey. Health, medical and demographic history, height and weight, waist and hip circumferences, and blood pressure were recorded. HbA1c and low-density lipoprotein cholesterol (LDL-C) level were tested. All of these data were measured 3 months later at the conclusion of the study intervention.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: May 2014
• Est. primary completion date: May 2014
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• All diabetes, aged more than 18 years old. No limit for HbA1c was defined

Exclusion Criteria:

• patients have any severe complications such as end phase of diabetic nephropathy or proliferative retinopathy. patients who cannot use smart phone.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Related Conditions & MeSH terms

• Diabetes Mellitus

Intervention

Other:
• Welltang
The intervention group installed Welltang (downloaded from www.welltang.com for free) designed by Shanghai Geping Information and Technique Company Ltd (Shanghai, China) on their cell phones. Welltang is a cell phone- based diabetes management application that consists of three main parts: knowledge, self-management, communication between patients and clinicians

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
First Affiliated Hospital of Zhejiang University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	HbA1c		3 months	No
Secondary	blood pressure		3 months	No
Secondary	low density lipoprotein cholesterol		3 months	No